how to take a glp 1 To: Use GLP-1 Injections A diabetes drug. Then a

The study found increased risk in both patients with type 2 diabetes and patients using semaglutide for overweight or obesity, but the authors noted that the study was observational and could not prove that semaglutide directly caused NAION

People with a personal or family history of thyroid cancer, pancreatitis (an inflamed pancreas) and gallbladder disease are at greater risk for serious complications and should not take weight-loss medication

Ozempic Lawsuit Gastroparesis and NAION Vision Impairment From Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, Zepbound GLP-1 RA Our Ozempic lawsuit lawyers are investigating cases where individuals have suffered gastroparesis/stomach paralysis (frozen stomach) or vision loss after using the weight loss drugs Ozempic, Wegovy, or Rybelsus

Factors That Affect Settlement Amounts Duration: Longer-lasting complications may increase payouts

For example, patients using semaglutide achieve an average weight loss of 4.5 kg, which compares favorably to clinical trial results ranging from 3.5 to 6.5 kg

Gastrointestinal side effects occur most often, including nausea, vomiting, and constipation